The Office of Technology Development will offer the Innovation to Impact Series
Session 3 – “Patents 101 – First Do No Harm.” Topics to be discussed will be: What is a Patent?;
How/why does a public disclosure affect patentability?; Types of public disclosures; How to publish
without hurting your patent rights; and Key milestones of the patent process.
This session will occur on September 27th from Noon- 1:00 pm in Biomedical Research Center
Building, Room 103. Lunch will be provided.
Please RSVP to firstname.lastname@example.org by September 24th. Space is limited to the first 15 attendees.
NIH Office of Disease Prevention: Call for Nominations, Early-Stage investigator Lecture
Letters of Intent Due: September 26, 2017
Nominations Due: October 27, 2017
Winner Notified: January 15, 2018
Lecture Presentation at the NIH: March 19, 2018
NIH announces the 2018 call for nominations for the ODP Early-Stage Investigator Lecture. The
award is made annually to an early-career scientist who has made significant research contributions
and is poised to become a leader in prevention research, but who has not yet successfully competed
for a substantial NIH-Supported research project. The award winner will be invited with all travel
expenses covered, to give a lecture at the NIH on Monday, March 19, 2018. The awardee will also
be offered an opportunity for professional networking with NIH program directors and scientists.
Please email email@example.com with any questions.
For additional information go to:
Research E-Newsletter Call for Contributions
The OUHSC Office of the Vice President for Research would like to invite you to submit either your
work or that of your peers, staff, and/or students to be included in the quarterly research e-newsletter.
The purpose of the e-newsletter is to provide information concerning the important and exciting
research and scholarly work being conducted by our OUHSC faculty, students, and staff.
Please send a brief synopsis of the research that was conducted or published between February 1,
2017 and August 31, 2017 and any accompanying figure/image/graph. The deadline to submit
information is Tuesday, September 26, 2017, to Samantha Skrepnek (firstname.lastname@example.org).
Information included in the newsletter will be at the discretion of the Vice President for Research.
Categories of work to be highlighted may include, but are not limited to, the following:
1. Research Award Highlights (e.g., significant awards received);
2. Research Achievement Highlights (e.g., important activities and achievements of OUHSC faculty
and others, news/appointments to prestigious leadership positions/committees);
3. Research Publication Highlights (e.g., publications in top tier journals/books/reports);
4. New Research Faculty Introductions;
5. Student and Fellow Recognition (e.g., poster presentation awards and podium presentations at
national meetings); and
6. Technology Development (e.g., patents, spin-off companies/corporate collaborations, commercial
If there are any questions concerning the newsletter or newsletter submission, please do not hesitate
to contact Samantha Skrepnek at the above-listed email address.
Requests for Proposals for OMRF COBRE Pilot Projects: Interdisciplinary Research in
Vascular Biology - Deadline September 30, 2017 See attached letter for additional information.
http://research.ouhsc.edu/Portals/1329/Assets/Documents/Cardio_COBRE Pilot Projects Invitation 2017.pdf?ver=2017-09-11-074601-747
OU Growth Fund Application Now Available – Receive up to $75,000
The University of Oklahoma Office of Technology Development is now accepting applications for the
Growth Fund, which helps to strengthen the commercial potential of disclosed University of Oklahoma
innovations. The program’s purpose is to move inventions closer to the market, including providing for
prototypes, additional research results, and/or “gap” funding to keep a program in place during transition.
Recipients from the OU Health Sciences Center can receive up to $75,000 in Growth Funds. The
application and more details are available at ou.edu/otd/growthfund. Applications are due by Sunday,
September 24. Please contact Annie Smith, Growth Fund Coordinator, at email@example.com or
(405) 325-0719 with any questions.
Physical Stresses: Keeping Us Alive and Well, An Interdisciplinary Research Symposium
on Mechanotransduction -- CALL FOR ABSTRACTS
The abstract submission deadline for the Symposium Physical Stresses: Keeping Us “Alive and Well” is
11:59 p.m. on Sunday, October 15, 2017. The Symposium, funded in part by a PHF Symposium Grant,
will be held on Friday, February 9, 2018, at the College of Allied Health Building. The Symposium will
consist of three keynote speakers, nine selected oral presentations, and a peer-reviewed poster session.
Please see attached Call for Abstracts. For more information, abstract submission guidelines, and upload/
submission link, go to:
http://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF Call for Abstracts.pdf?ver=2017-09-11-075353-497
Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS
The abstract submission deadline for the HHDC 2017 Research Symposium is Friday, September 29th
Abstracts must be received by 5 p.m. HHDC 2017 Research Symposium will be held on Friday, November
10, 2017 at the Samis Education Center in Children’s Hospital in Oklahoma City. The Symposium will
consist of selected oral presentations, a poster session, and a keynote address by Steven Kahn, M.B.,
Ch.B, Professor of Medicine, Director, Diabetes Research Center; University of Washington. For abstract
submission guidelines and to RSVP for this free event, please go to:
http://www.haroldhamm.org/Research/Symposium.aspx Please contact Katie-Hoefling@ouhsc.edu with
any questions for this event.
ORA Noon Conference
The ORA Submission Process: A Review for New Investigators - This talk is intended to
provide a brief general overview of working with ORA when submitting or transferring a grant proposal.
We will briefly discuss the process, where to find forms and information, deadlines and waivers, and
resources. Wednesday, September 20, 2017; Bird Library Auditorium, LIB-299 from 11:30 pm - 1:00 pm
NIH Request for Information (RFI): Important Considerations for Potential Creation of an Open-Access
Nuclear Magnetic Resonance (NMR) Data Repository (NOT-AT-17-015)
Notice of Change of Study Section Assignment for AHRQ's PA-17-246 "Health Information Technology
(IT) to Improve Health Care Quality and Outcomes" (NOT-HS-17-020)
Notice of Changes to NIH Policy for Issuing Certificates of Confidentiality (NOT-OD-17-109)
Notice of Modification to PAR-17-465 "Bench Testing Therapeutic/Indication Pairing Strategies
Notice of Pre-Application Webinar and Frequently Asked Questions for RFA-HL-18-019 "Increasing
Use of Cardiovascular and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Agency for Healthcare Research and Quality and Patient-Centered Outcomes Research Institute
Learning Health Systems Mentored Career Development Program (K12) (RFA-HS-17-012)
Deadline January 24, 2018
Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human
Genetic Variants (U54) (RFA-NS-18-001) – Deadline November 15, 2017
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical
Trial Not Allowed) (PAR-17-475) – Deadline November 27, 2017
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical
Trial Not Allowed) (PAR-17-476) – Deadline November 27, 2017
NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and
Promote Scientific Leadership (R25) (RFA-DK-17-015) – Deadline December 5, 2017
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening
(R43) (RFA-ES-17-008) – Deadline January 12, 2018
Research on Transgender Health (R21) (PA=17-477) – Deadline October 16, 2017
Research on Transgender Health (R01) (PA-17-478) – Deadline October 5, 2017
OTHER FEDERAL DEADLINES
Department of Defense (DOD) – Hearing Restoration Research Program/Translational Research
Award (TRA) – Deadline for Required Letter of Intent October 25, 2017
DOD – Hearing Restoration Research Program/Focused Research Award (FRA) – Deadline for
Required Letter of Intent October 25, 2017
DOD – Orthotics and Prosthetics Outcomes Research Program – Deadline for Required Letter of
Intent October 10, 2017
New Clinical Study Opportunities
Please note this is NOT a solicitation for study subjects
Parexel is looking for Principal Investigators to participate in the following clinical studies.
- Opportunity to participate in a Phase III Clinical Study in locally advanced or metastatic gastric
cancer that responded to platinum-based first-line chemotherapy – Reference Number 236155
- Rheumatologists interested in a SLE study
- COPD study
- Astra Zeneca Triple Negative Breast Cancer Survey 234970
A new phase II clinical study with Olaparib, AZD6738 and AZD1775, for patients with
metastatic Triple Negative Breast Cancer (TNBC) performed by AstraZeneca AB
- 106671 Janssen MDD trial opportunity
Indication: treatment resistant depression (TRD)
Please contact Scott Davis at firstname.lastname@example.org if you would like to receive more information on
any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed
to the Office of Research Administration.